Journal for ImmunoTherapy of Cancer (Nov 2023)

638 Characterisation of the immune response to EO2401, a new immunotherapy approach against cancer, plus nivolumab in recurrent glioblastoma: The EOGBM1–18/ROSALIE study

  • Agostina Stradella,
  • Francois Ghiringhelli,
  • Ana Maia,
  • Macarena Gonzalez,
  • Cécile Gouttefangeas,
  • Ulrich Herrlinger,
  • David Reardon,
  • Ahmed Idbaih,
  • Patrick Wen,
  • Ghazaleh Tabatabai,
  • Wolfgang Wick,
  • Mirjam Renovanz,
  • Maria Vieito Villar,
  • Christophe Bonny,
  • Joao Gamelas Magalhaes,
  • Hélène Toussaint,
  • Jean-Michel Paillarse,
  • Marta GilMartin,
  • Iris Mildenberger,
  • Michael C Burger,
  • Alice Hervieu,
  • Mehdi Touat,
  • Antje Wick

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0638
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.